A balanced diet, regular exercise and healthy lifestyle habits remain essential for sustainable results
373, no
right upper quadrant pain, fever or jaundice (possible gallbladder disease)
While you may see lots of dramatic weight loss stories on social media, studies have shown that among adults who were overweight or obese, those who injected semaglutide lost nearly 15% of their body weight after 68 weeks
Keywords , MASH , GLP-1 receptor agonists , hepatic steatosis , metabolic dysfunction , tirzepatide , semaglutide , survodutide 0 2 INTRODUCTION Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease (NAFLD), has emerged as the predominant hepatic pathology worldwide, impacting roughly twenty-five percent of the adult population [1,2]